[Evaluation of antihymenolepidose activity of the compound MCT-03].
Mikhaĭlitsyn
F S
FS
Trusov
S N
SN
Sevbo
D P
DP
Gitsu
G A
GA
Malakhova
A Iu
AIu
D000818:Animals; D000923:Anticestodal Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains
D000923:Anticestodal Agents; D001549:Benzamides; C548116:N-(3-chloro-4-methylphenyl)-2-acetyloxy-3,5-dibromobenzamide